Canadian application, no grantCanada
Diabetes treatment
CA 2249454 A1 · Owner: Smith, Margaret Elizabeth · Inventors: Smith, Margaret Elizabeth
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Diabetes mellitus type I or II is treated by use of a peptide including an amino acid sequence corresponding to that of an active C-terminal fragment of .beta.-endorphin or an active analogue of a C-terminal fragment of .beta.endorphin.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 21, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 21, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 21, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 21, 1997
GrantedNo grant recorded
Term endedMarch 21, 2017
Patent numberCA 2249454 A1
Classification (IPC)A61K38/33 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.